Blogg

SWHR Comments to NAM on COVID-19 Vaccine Allocation Framework

SWHR provided comments in response to the National Academy of Medicine (NAM) “Discussion Draft of the Preliminary Framework for Equitable […]

SWHR Recommendations to FDA for PDUFA Reauthorization for FY 2023-27

SWHR provided comments as a follow-up to the U.S. Food and Drug Administration (FDA) public meeting regarding the proposed recommendations […]

SWHR Feedback to NIH on Improving Biomedical Animal Research

SWHR provided comments to the National Institutes of Health (NIH) Advisory Committee to the Director Working Group on Enhancing Rigor, […]

SWHR Comments to NIA on Alzheimer’s Research Gaps and Opportunities

SWHR Endorses AHRQ Funding Bill for Research on Critical Pandemic Health System Issues

SWHR signed on to a letter urging Speaker Nancy Pelosi (D-CA) and House Minority Leader Kevin McCarthy (R-CA) to endorse H.R. […]

SWHR Comments to NIDA on Strategic Plan for FYs 2021-2025

SWHR provided input to the National Institute on Drug Abuse (NIDA) on its Strategic Plan Outline for Fiscal Years (FYs) […]

SWHR Thanks HHS for Renewal of Public Health Emergency Declaration for COVID-19

SWHR and 90 other stakeholders thanked Department of Health and Human Services (HHS) Secretary Alex Azar for renewing the public […]

SWHR Applauds Uterine Fibroids Research and Education Act

SWHR President and CEO Kathryn Schubert, MPP, released the following statement in support of the Uterine Fibroids Research and Education […]

SWHR Urges Funding of CDC’s Surveillance for Emerging Threats to Moms and Babies Program

SWHR signed on to a letter to Senate leadership requesting $100 million for the Surveillance for Emerging Threats to Moms […]

SWHR Urges Inclusion of Expanded Pregnancy-Related Medicaid Coverage in COVID-19 Legislation

SWHR signed on to a letter urging Speaker Nancy Pelosi (D-CA), Senate Majority Leader Mitch McConnell (R-KY), House Minority Leader […]